The American Journal of Cardiology · 2022 · 10 citations · 22 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyClinical PharmacologyMeta-analysisCardiac MedicationsCardiac PharmacotherapyCardiovascular PharmacologyHeart FailureHeart Failure PharmacotherapyNetwork Meta-analysisAngiotensin Ii Receptor BlockersAngiotensin Receptor Neprilysin InhibitionAngiotensin Receptor-neprilysin InhibitorsRenin-angiotensin System BlockadeRenin-angiotensin System InhibitorsRenin-angiotensin-aldosterone System BlockadeRenin-angiotensin-aldosterone System InhibitionRenin-angiotensin-aldosterone System Inhibitors
22
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt et al. · BMJ · 2021 · 95K citations · Full text
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins, Doug Altman, Peter C Gøtzsche et al. · BMJ · 2011 · 34.2K citations · Full text
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
John J.V. McMurray, Milton Packer, Akshay S. Desai et al. · New England Journal of Medicine · 2014 · 6.8K citations · Full text
Medicine, Cardiology, Pharmacology +11